ProPhotonix Limited PROPHOTONIX LIMITED ADOPTS RIGHTS AGREEMENT (2948Q)
August 29 2014 - 2:01AM
UK Regulatory
TIDMPPIR TIDMPPIX
RNS Number : 2948Q
ProPhotonix Limited
29 August 2014
August 29, 2014
PROPHOTONIX LIMITED
("ProPhotonix" or the "Company")
ADOPTS STOCKHOLDER RIGHTS AGREEMENT
AND AMENDS BY-LAWS
ProPhotonix Limited, (London Stock Exchange - AIM: PPIX and
PPIR; OTC: STKR), a designer and manufacturer of LED illumination
systems and laser diode modules with operations in Ireland and the
United Kingdom, today announces that its Board of Directors has
adopted a stockholder rights agreement (the "Rights Plan") and
declared a dividend distribution of one common stock purchase right
on each outstanding share of its Common Stock. The Board of
Directors, in accordance with Delaware law, approved the adoption
of the Rights Plan and determined that it is in the best interest
of all the Company's stockholders. As set out on the Company's
website, the Company is not subject to the City Code on Takeovers
and Mergers.
The rights are designed to ensure that all stockholders of the
Company realize the long-term value of their investment in the
Company; that they receive fair and equal treatment in the event of
a potential takeover of the Company; that they are protected in the
event of any of a two-tier or partial tender offer, open market
accumulations and other tactics designed to gain control of the
Company without the payment of a fair price by an offeror; and to
enhance the Board of Directors' ability to negotiate with a
prospective acquiror.
Among other benefits, the Rights Plan enables the Company to
continue to conduct an orderly, thorough and deliberative process
of reviewing the Company's strategic alternatives and is designed
to reduce the likelihood that any person or group of affiliated or
associated parties would accumulate 20% or more of the stock or
engage in takeover tactics without paying a fair price to all
stockholders. The issuance of the rights under the Rights Plan is
not intended to prevent a transaction that is determined by the
Board of Directors to be fair, advisable and in the best interests
of all Company stockholders.
Each right will initially entitle stockholders to buy one share
of Common Stock of the Company, par value $0.001 per share, at an
exercise price of $0.30, in the event the rights become
exercisable, subject to adjustment and the terms of the Rights
Plan. In general, the rights will become exercisable if a person or
group of affiliated or associated parties becomes the beneficial
owner of 20% or more of the outstanding Common Stock of the Company
or announces a tender offer for 20% or more of the outstanding
Common Stock of the Company. The recent share purchase by 600 Group
plc ("600 Group") of 26% of the Company's outstanding shares is not
a triggering event because it is an ownership position existing
prior to the adoption of the Rights Plan. In the event 600 Group
acquires any additional shares, a triggering event will take place.
The Board of Directors will in general be entitled to cause the
redemption of the rights at $0.001 per right at any time before the
triggering ownership threshold is crossed.
In the event that the rights become exercisable due to the
triggering ownership threshold being crossed, each right will
entitle its holder to purchase a number of shares of Common Stock
(or cash, other assets, debt securities of the Company, or any
combination thereof equivalent in value thereto) with an aggregate
value equal to twice the exercise price (i.e., purchase a number of
shares of Common Stock with an aggregate market value of $0.60 as
of the triggering event for $0.30). Rights held by the triggering
person(s) or group of affiliated or associated parties will become
void and will not be exercisable to purchase shares at the reduced
purchase price. After the rights have become exercisable, the Board
of Directors may choose to exchange the rights (other than rights
owned by the triggering person which will have become void), in
whole or in part, for shares of Common Stock at an exchange ratio
of one share of Common Stock (or cash, other assets, debt
securities of the Company, or any combination thereof equivalent in
value thereto) per right.
A summary of the terms of the Rights Plan will be mailed to
stockholders of record and will be available, together with the
Rights Plan, on the Company's website at
http://www.prophotonix.com/investors/Stockinfo.aspx.
The dividend distribution of rights under the Rights Plan was
paid on August 28, 2014, to stockholders of record as of the close
of business on August 28, 2014. The rights are not currently
tradeable, and should a stockholder sell the underlying holding of
ProPhotonix shares, these rights will transfer to the new owner of
those shares. In addition, any new shares of Common Stock of the
Company that become outstanding between August 28, 2014 and the
earlier of a triggering event or the termination of the Rights
Plan, will receive the same right under the Rights Plan. The rights
will expire on August 28, 2017, unless the rights are earlier
redeemed or exchanged by the Company. The rights distribution is
not taxable to stockholders.
Simultaneously with the adoption of the Rights Plan, and in
accordance with Delaware law, the Company amended and restated its
By-laws to, among other things, add an advance notice provision
relating to stockholder action at meetings, a procedural provision
governing stockholder action by written consent and a provision
relating to stockholder ownership disclosure requirements. A copy
of the amended and restated By-laws is available on the Company's
website at
http://www.prophotonix.com/investors/Corporate-Governance/by-laws.aspx.
Enquiries:
ProPhotonix Limited Tel: +1 603 893 8778
Tim Losik, President and CEO ir@prophotonix.com
N+1 Singer Tel: +44 (0) 207 496
Andrew Craig/ Ben Wright 3000
Nominated Adviser and Broker
About ProPhotonix
ProPhotonix Limited, headquartered in Salem, New Hampshire, is
an independent designer and manufacturer of diode-based laser
modules and LED systems for industry leading OEMs and medical
equipment companies. In addition, the Company distributes premium
diodes for Oclaro, Osram, QSI, Panasonic, and Sony. The Company
serves a wide range of markets including the machine vision,
industrial inspection, security, and medical markets. ProPhotonix
has offices and subsidiaries in the U.S., Ireland, U.K., and
Europe. For more information about ProPhotonix and its innovative
products, visit the Company's web site at www.prophotonix.com.
Forward Looking Information
This news release contains forward-looking statements (within
the meaning of the Private Securities Litigation Reform Act of
1995) that involve risks and uncertainty. These forward-looking
statements include statements as to the intent of the Rights Plan
to enable the Company's stockholders to realize the long-term value
of their investment in the Company, the potential outcome and
impact of the Company's ongoing review of strategic alternatives,
and the anticipated impact of the Rights Plan on the Company's
strategic alternatives review process. There can be no assurance
that the Rights Plan will have the intended impact, or that the
Company's review of strategic alternatives will lead to any
transaction, result in increased value to its stockholders or the
realization of long-term value by stockholders. Economic, business,
market, regulatory, technology and other factors could cause our
actual future results to differ materially from those expressed in
our forward-looking statements.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQKFDDOBKDDFB
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From Nov 2023 to Nov 2024